Shares Outstanding Shares Outstanding n/a Close	833.11M
Shares Change (YoY) Shares Change (YoY) n/a Close	0.06%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0.01%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	14.21%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	134,194
FTD / Avg. Volume FTD / Avg. Volume n/a Close	6.39%

Short Selling Information

The latest short interest is 14.93M, so 1.79% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	14.93M
Short % of Shares Out Short % of Shares Out n/a Close	1.79%
Short % of Float Short % of Float n/a Close	2.45%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	8.39

Valuation Ratios

The PE ratio is 18.45 and the forward PE ratio is 0.23. Dr. Reddy's Laboratories's PEG ratio is 0.8.

PE Ratio PE Ratio n/a Close	18.45
Forward PE Forward PE n/a Close	0.23
PS Ratio PS Ratio n/a Close	3.68
Forward PS Forward PS n/a Close	0
PB Ratio PB Ratio n/a Close	3.66
P/FCF Ratio P/FCF Ratio n/a Close	57.09
PEG Ratio PEG Ratio n/a Close	0.8

Financial Ratio History

Enterprise Valuation

Dr. Reddy's Laboratories has an Enterprise Value (EV) of 1,040.3B.

EV / Sales EV / Sales n/a Close	3.73
EV / EBITDA EV / EBITDA n/a Close	11.77
EV / EBIT EV / EBIT n/a Close	22.9
EV / FCF EV / FCF n/a Close	57.8

Financial Position

The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.07.

Current Ratio Current Ratio n/a Close	2.58
Quick Ratio Quick Ratio n/a Close	1.92
Debt / Equity Debt / Equity n/a Close	0.07
Debt / EBITDA Debt / EBITDA n/a Close	0.23
Debt / FCF Debt / FCF n/a Close	1.11
Interest Coverage Interest Coverage n/a Close	39.58

Financial Efficiency

Return on Equity is 19.85% and Return on Invested Capital is 17.18%.

Return on Equity Return on Equity n/a Close	19.85%
Return on Assets Return on Assets n/a Close	14.37%
Return on Invested Capital Return on Invested Capital n/a Close	17.18%
Revenue Per Employee Revenue Per Employee n/a Close	$10,321,058.86
Profits Per Employee Profits Per Employee n/a Close	$2,058,710.44
Employee Count Employee Count n/a Close	27,048
Asset Turnover Asset Turnover n/a Close	0.72
Inventory Turnover Inventory Turnover n/a Close	1.82

Taxes

Income Tax Income Tax n/a Close	16.19B
Effective Tax Rate Effective Tax Rate n/a Close	22.52%

Stock Price Statistics

The stock price has increased by 8.9% in the last 52 weeks. The beta is 0.39, so Dr. Reddy's Laboratories's price volatility has been higher than the market average.

Beta Beta n/a Close	0.39
52-Week Price Change 52-Week Price Change n/a Close	8.9%
50-Day Moving Average 50-Day Moving Average n/a Close	13.85
200-Day Moving Average 200-Day Moving Average n/a Close	14.55
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	74.69
Average Volume (20 Days) Average Volume (20 Days) n/a Close	2,098,552

Income Statement

In the last 12 months, Dr. Reddy's Laboratories had revenue of 279.16B and earned 55.68B in profits. Earnings per share was 66.8.

Revenue Revenue n/a Close	279.16B
Gross Profit Gross Profit n/a Close	163.61B
Operating Income Operating Income n/a Close	67.73B
Net Income Net Income n/a Close	55.68B
EBITDA EBITDA n/a Close	88.42B
EBIT EBIT n/a Close	73.58B
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	66.8

Full Income Statement

Balance Sheet

The company has 7.11B in cash and 20.02B in debt, giving a net cash position of -12.91B.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	7.11B
Total Debt Total Debt n/a Close	20.02B
Net Cash Net Cash n/a Close	-12.91B
Retained Earnings Retained Earnings n/a Close	265.26B
Total Assets Total Assets n/a Close	481.06B
Working Capital Working Capital n/a Close	121.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 45.43B and capital expenditures -27.43B, giving a free cash flow of 18B.

Operating Cash Flow Operating Cash Flow n/a Close	45.43B
Capital Expenditures Capital Expenditures n/a Close	-27.43B
Free Cash Flow Free Cash Flow n/a Close	18B
FCF Per Share FCF Per Share n/a Close	21.59

Full Cash Flow Statement

Margins

Gross margin is 58.61%, with operating and profit margins of 24.26% and 19.95%.

Gross Margin Gross Margin n/a Close	58.61%
Operating Margin Operating Margin n/a Close	24.26%
Pretax Margin Pretax Margin n/a Close	25.74%
Profit Margin Profit Margin n/a Close	19.95%
EBITDA Margin EBITDA Margin n/a Close	31.67%
EBIT Margin EBIT Margin n/a Close	24.26%
FCF Margin FCF Margin n/a Close	6.45%

Dividends & Yields

RDY pays an annual dividend of $0.1, which amounts to a dividend yield of 0.59%.

Dividend Per Share Dividend Per Share n/a Close	$0.10
Dividend Yield Dividend Yield n/a Close	0.59%
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	-1.84%
Payout Ratio Payout Ratio n/a Close	12.13%
Earnings Yield Earnings Yield n/a Close	5.42%
FCF Yield FCF Yield n/a Close	1.75%

Dividend Details

Analyst Forecast

The average price target for RDY is $16.95, which is 9.1% higher than the current price. The consensus rating is "Strong Buy".

Price Target Price Target n/a Close	$16.95
Price Target Difference Price Target Difference n/a Close	9.1%
Analyst Consensus Analyst Consensus n/a Close	Strong Buy
Analyst Count Analyst Count n/a Close	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	$1550.43
Lynch Upside Lynch Upside n/a Close	9877.03%
Graham Number Graham Number n/a Close	711.27
Graham Upside Graham Upside n/a Close	4477.03%

Stock Splits

The last stock split was on Nov 5, 2024. It was a forward split with a ratio of 5:1.

Last Split Date Last Split Date n/a Close	Nov 5, 2024
Split Type Split Type n/a Close	forward
Split Ratio Split Ratio n/a Close	5:1

Scores

Altman Z-Score Altman Z-Score n/a Close	2.36
Piotroski F-Score Piotroski F-Score n/a Close	4